Research ExplorerScientific StaffAngela Schulz Publications

Dr.med. ID: 55805

Angela Schulz

graph of relations
Affiliations
51 - 60 out of 60Page size: 50

Publications

  1. 2022

  2. Natural history of MRI brain volumes in patients with neuronal ceroid lipofuscinosis 3: a sensitive imaging biomarker

    Hochstein, J-N., Schulz, A., Nickel, M., Lezius, S., Grosser, M., Fiehler, J., Sedlacik, J. & Löbel, U., 10.2022, In: NEURORADIOLOGY. 64, 10, p. 2059-2067 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Therapeutic Management of COVID-19 in a Pediatric Patient with Neurodegenerative CLN2 Disease and ICV-Enzyme Replacement Therapy: A Case Report

    Schwering, C., Apostolidou, S., Deindl, P., Christner, M., Knobloch, J. K-M., Herrmann, J., Kobbe, R., Schulz, A., Singer, D. & Ebenebe, C. U., 10.2022, In: NEUROPEDIATRICS. 53, 5, p. 381-384 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Visual perception and macular integrity in non-classical CLN2 disease

    Atiskova, Y., Wildner, J., Wibbeler, E., Nickel, M., Spitzer, M. S., Schwering, C., Schulz, A. & Dulz, S., 11.2022, In: GRAEF ARCH CLIN EXP. 260, 11, p. 3693-3700 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2023

  6. Ongoing retinal degeneration despite intraventricular enzyme replacement therapy with cerliponase alfa in late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2 disease)

    Dulz, S., Schwering, C., Wildner, J., Spartalis, C., Schuettauf, F., Bartsch, U., Wibbeler, E., Nickel, M., Spitzer, M. S., Atiskova, Y. & Schulz, A., 10.2023, In: BRIT J OPHTHALMOL. 107, 10, p. 1478-1483 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Language Delay in Patients with CLN2 Disease: Could It Support Earlier Diagnosis?

    Nickel, M., Gissen, P., Greenaway, R., Cappelletti, S., Hamborg, C., Ragni, B., Ribitzki, T., Schulz, A., Tondo, I. & Specchio, N., 12.2023, In: NEUROPEDIATRICS. 54, 6, p. 402-406 5 p.

    Research output: SCORING: Contribution to journal › Short publication › Research › peer-review

  8. 2024

  9. Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study

    Schulz, A., Specchio, N., de Los Reyes, E., Gissen, P., Nickel, M., Trivisano, M., Aylward, S. C., Chakrapani, A., Schwering, C., Wibbeler, E., Westermann, L. M., Ballon, D. J., Dyke, J. P., Cherukuri, A., Bondade, S., Slasor, P. & Cohen Pfeffer, J., 01.2024, In: LANCET NEUROL. 23, 1, p. 60-70 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. The parent and family impact of CLN3 disease: an observational survey-based study

    Schulz, A., Patel, N., Brudvig, J. J., Stehr, F., Weimer, J. M. & Augustine, E. F., 18.03.2024, In: ORPHANET J RARE DIS. 19, 1, p. 125

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Exploring concurrent validity of the CLN2 Clinical Rating Scale: Comparison to PedsQL using cerliponase alfa clinical trial data

    Specchio, N., Gissen, P., de Los Reyes, E., Olaye, A., Camp, C., Curteis, T., Griffiths, A., Butt, T., Cohen-Pfeffer, J., Slasor, P., Sisic, Z., Jain, M. & Schulz, A., 22.05.2024, In: PLOS ONE. 19, 5, p. e0302382

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. OCT Biomarkers in Ocular CLN2 Disease in Patients Treated With Intraventricular Enzyme Replacement Therapy

    Huang, W. C., Ohnsman, C. M., Atiskova, Y., Falabella, P., Spitzer, M. S., Schulz, A. & Dulz, S., 01.07.2024, In: INVEST OPHTH VIS SCI. 65, 8, p. 45

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Enzyme replacement therapy for CLN2 disease: MRI volumetry shows significantly slower volume loss compared to a natural history cohort

    Gaur, P., Gissen, P., Biswas, A., Mankad, K., Sudhakar, S., D'Arco, F., Schulz, A., Fiehler, J., Sedlacik, J. & Löbel, U., 08.07.2024, In: AM J NEURORADIOL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 Next